In vertebrate development, a prominent feature of several cell lineages is the coupling of cell cycle regulation with terminal differentiation. We have investigated the basis of this relationship in the skeletal muscle lineage by studying the effects of the proliferation-associated regulator, c-myc, on the differentiation of MyoD-initiated myoblasts. Transient cotransfection assays in NIH 3T3 cells using MyoD and c-myc MyoD (17, 54) , myogenin (20, 59), and Myf-5 (7) and the rat gene encoding MRF4 (47) which is called herculin in mice (37) and Myf-6 in humans (6). All share a highly similar 57-amino-acid B-HLH domain characterized by a strongly basic region in the amino portion followed by a potential helix-loop-helix (HLH) structure (40). Similar domains are also found in an extended family of nuclear proteins (reviewed in reference 31). In vertebrates, these include the myc family of protooncogenes (reviewed in reference 14), twist (28), achaete-scute (29), and the E12 and E47 proteins, first identified as binding to the immunoglobulin K-chain enhancer (40).
During skeletal muscle development, multipotential precursor cells progress through a determined myoblast stage before differentiating to become myocytes. While precursors and myoblasts proliferate extensively, withdrawal from the cell cycle is required for differentiation (13) . The onset of differentiation is characterized by the expression of genes that code for muscle-specific enzymes, contractile proteins, and receptors that are not expressed in myoblasts (reviewed in reference 48). The determination step that establishes a cell as a myoblast can be forced in many fibroblast cell lines by expression of any one of the four members of the MyoD family of myogenic regulatory genes. This family (reviewed in reference 42) includes genes encoding MyoD (17, 54) , myogenin (20, 59) , and Myf-5 (7) and the rat gene encoding MRF4 (47) which is called herculin in mice (37) and Myf-6 in humans (6) . All share a highly similar 57-amino-acid B-HLH domain characterized by a strongly basic region in the amino portion followed by a potential helix-loop-helix (HLH) structure (40) . Similar domains are also found in an extended family of nuclear proteins (reviewed in reference 31). In vertebrates, these include the myc family of protooncogenes (reviewed in reference 14) , twist (28) , achaete-scute (29) , and the E12 and E47 proteins, first identified as binding to the immunoglobulin K-chain enhancer (40) .
In vitro studies of DNA binding and protein-protein interactions, together with mutagenesis studies, show that the B-HLH domain is functionally important (9, 16, 34, 41 (16) .
Further support for the roles of the basic and HLH regions in producing active DNA-binding proteins comes from the nature of the protein Id (2) . Id contains an HLH domain but not an adjacent basic region. It can associate in vitro with MyoD, E12, and E47 and inhibit their binding to DNA. In vivo, overexpression of Id inhibits the trans-activation of the muscle creatine kinase (MCK) enhancer upon cotransfection with MyoD. Thus, Id, which is widely expressed, appears to negatively regulate the differentiation functions of tissuespecific B-HLH complexes by sequestering components of such complexes in inactive hetero-oligomers (2) .
The structural similarity of the MyoD family of regulators with the myc family of proto-oncogenes is interesting because c-myc is strongly implicated in the control of cell proliferation in several different cell lineages, including muscle (30, 51) . During myogenesis, c-myc is expressed in proliferating myoblasts, but myc mRNA and protein levels drop substantially when these cells withdraw from the cell cycle and differentiate (22, 51) . myc is further implicated in the proliferation-differentiation switch by the fact that differentiation-defective derivatives of some myoblast cell lines fail to down-regulate c-myc expression (51) . Other studies show that ectopic myc expression can interfere with myoblast differentiation (18, 24, 50) . Conversely, MyoD has recently been shown to inhibit the serum-induced progression of quiescent cells into S phase (iSa, 52) . Considered together, the pattern of myc expression, its sequence similarity to MyoD, its nuclear localization, and the apparent effects of ectopic expression make attractive the possibility that myc and MyoD play pivotal and opposing roles in controlling the differentiation decision.
In this study we show that c-myc can inhibit the differen-tiation of cells made myogenic by transfection of a gene encoding MyoD in both transient and stable assays of NIH 3T3 cells. An important virtue of this system is the ability to study the activities of ectopic MyoD, myogenin, and c-myc in the absence of Myf-5, herculin, and endogenous MyoD, as these genes are not activated in these cells by MyoD (37, 55) . Our results show that MyoD and myogenin are not sufficient, acting alone or together, to drive muscle differentiation in the presence of high levels of c-myc. Moreover, the myc suppression can function independently of Id activity, suggesting that there are at least two negative regulators normally expressed in undifferentiated myoblasts that can prevent differentiation.
MATERUILS AND METHODS Expression vector constructions. The MT-myc gene in 3T3
MT-myc cells contains the metallothionein-I promoter (EcoRI to BglII, [38] ) fused to a c-myc minigene containing the last 33 nucleotides (nt) of the first intron (from the XbaI site), exons 2 and 3 (without intron 2) up to the Nsil site (3), and the metallothionein-I polyadenylation signal sequence. The MyoD expression vehicle pEMclls was a gift from Andrew Lassar (17) . Simian virus 40 (SV40)-promoted genes used in the transient cotransfections were all constructed in pECE (21), a 2.9-kb vector which contains the SV40 early promoter and T antigen polyadenylation signal sequences flanking a multiple cloning site. pSVclls contains the 1. 8-kb EcoRI fragment (MyoD cDNA) from pEMclls cloned into the EcoRI site of pECE. pSVmyc contains the 1.4-kb XbaI-to-XhoI fragment of c-myc (from MT-myc) cloned into the XbaI site of pECE via a three-step ligate-blunt-ligate procedure. pSVrGEN contains rat myogenin cDNA (a gift from Woody Wright) as a 1.5-kb EcoRI fragment from BS-il, which contains the cDNA (59), cloned into the EcoRI site of pECE. Standard procedures were used for all manipulations (36) .
Cell culture and DNA transfections. NIH 3T3 cells obtained from the American Type Culture Collection were grown in Dulbecco's Modified Eagle's Medium (DMEM) (Flow)-10%o calf serum (GIBCO or Irvine Scientific) supplemented with penicillin (10 U/ml) and streptomycin (10 p,g/ml) (Irvine Scientific). 3T3 MT-myc cells were grown in DMEM-10% fetal bovine serum (FBS) (HyClone). Prior to stable transfection with the MyoD expression vehicle pEMclls, NIH 3T3 cells and 3T3 MT-myc cells were plated on 10-cm-diameter gelatin-coated plates in DMEM-109o FBS. They were transfected by calcium phosphate coprecipitation (57) with 10 ,ug of pEMclls-1 p.g of pY3 (which confers resistance to hygromycin B [4] NIH 3T3 cells used in transient transfections were plated on uncoated dishes in DMEM-10% calf serum. Transfections were performed as described above, but the glycerol shock was omitted. Plasmid mixtures are described in the figure legends. Forty-eight hours after transfection, plates were fed DMEM-2% horse serum-2 ,ug of insulin per ml to induce differentiation. Three days later plates were fixed and immunostained for the myosin heavy chain (MHC) with horseradish peroxidase as described by Rhodes and Konieczny (47) by using the monoclonal antibody MF20 (1) and Amersham secondary reagents.
RNA isolation and analysis. RNAs were prepared by the method of Chomczynski and Sacchi (12) from cells on 15-cm-diameter dishes by using 4 ml of guanidinium solution. Relevant transcripts were analyzed by ribonuclease protection assays. Hybridizations were done in 30 >i± of 80%o deionized formamide-40 mM PIPES (pH 6.4) [piperazine-N,N'-bis(2-ethanesulfonic acid)]-l mM EDTA-400 mM NaCl under mineral oil at 50°C for 12 h by using 2.5 or 5 p.g of total RNA and 5 x 109 radiolabeled probe molecules per hybridization. Unhybridized probes were digested by adding 300 ,ul of 10 mM Tris (pH 7.5)-S5 mM EDTA-300 mM NaCl- all contained the requisite amount of pECE vector such that the total molar amount of SV40 promoter in each transfection mixture was identical. NIH 3T3 cells were transfected with these mixtures along with the SV40-promoted bacterial chloramphenicol acetyltransferase gene (pSV2CAT) to control for significant transfection efficiency differences from plate to plate. After 3 to 4 days in differentiation medium, the cells were fixed and the number of MHC-positive cells were counted after immunostaining. The results of two such experiments (hatched and black bars) are shown in Fig. 1 . As MyoD is held constant and c-myc is increased, the number of differentiated muscle cells diminishes by up to 90%. These results suggest that c-myc has a strong inhibitory effect on the ability of MyoD to promote differentiation in NIH 3T3 cells. By comparison with prior observations of retroviral inhibition of primary myoblast differentiation (24) or transfections of naturally occurring myoblast cell lines (e.g., reference 18) in which the complement of muscle regulators already being expressed is unknown, the results in this system specifically show inhibition of MyoD-initiated differentiation.
myc overexpression inhibits MyoD-initiated differentiation in stable transfectants. There are likely to be important intermediate steps between expression of ectopic MyoD and activation of muscle-specific genes. Otherwise, any cell which expresses MyoD would become myogenic; but this is not the case (56) . However, while the transient assays show that c-myc inhibits MyoD-initiated myogenesis, the small fraction of cells which actually take up and express DNA are not suitable for further characterization of the regulatory pathway. We therefore constructed a set of NIH 3T3-based cell lines that are myogenic because of constitutive expression of a transfected MyoD cDNA. Some of these lines also carry a c-myc gene under the control of the mouse metallothionein-I promoter (MT-myc gene) which can be induced up to 10-fold above endogenous myc protein levels by supplementing the culture medium with zinc sulfate (54a). However, these MT-myc cells do not appear to be growth transformed, as they do not form foci in culture or tumors in nude mice, even when treated with zinc. A useful feature of conditional myc expression is that it helps to ensure that the phenotypic effects observed are attributable to transient overexpression of c-myc and not to long-term secondary effects of chronic myc expression or to the emergence of differentiation-defective derivatives, a possible factor in prior studies of the effects of myc on myogenesis. Myogenic derivatives of these MT-myc cells and of the parental NIH 3T3 cells were made in parallel transfections by using the MyoD expression vector pEMclls (17) . The myogenic potential of MyoD-transfected cell clones was evaluated by immunostaining for expression of MHC after cultivation for several days in a mitogen-poor differentiation medium. Several independent myogenic transformants in both 3T3 and 3T3 MT-myc backgrounds were subcloned, and the most myogenic of these were chosen for further study.
MyoD myoblasts carrying the zinc-inducible MT-myc gene (MT-myc/MyoDl cells) differentiate in the absence of added metal, but differentiation is suppressed in the presence of zinc. MyoD myoblasts lacking the metal-inducible myc gene (MyoDl cells) are unaffected by zinc and differentiate to similar extents in the presence or absence of added metal. This result is visualized by the immunocytochemical stain for MHC shown in Fig. 2A , and a quantitation is presented in Fig. 2B . Differentiated cells were scored by counting cells that stain positive for MHC; similar results have been obtained by immunostaining for MCK and by quantitating MCK RNA levels (data not shown). Differentiation was not completely suppressed when myc was induced, a result which is expected if the quantity of c-myc expressed is crucial for suppression, since immunostaining for c-myc has shown that it does not accumulate to uniformly high steady-state levels in all cells of the MT-myc line (54a). We conclude that in these cells, differentiation is specifically suppressed by the induction of MT-myc expression. myc suppresses differentiation even in the presence of MyoD. How are the differentiation phenotypes in these experiments related to the levels of MyoD and myc expression? To begin to answer this question, the levels of myc and MyoD transcripts were measured by a ribonuclease protection assay. Results shown in Fig. 3 confirm that in the MT-myc/MyoD line, myc transcripts from the transgene accumulate to significantly elevated levels in the presence of added zinc ( Fig. 3 ; in the 3.5-h exposure of the myc probe, compare lane 1 with 2 and lane 3 with 4 and in the longer exposure, compare lane 5 with 6). Lower myc levels are observed in the absence of added zinc when cells differentiated well, while the elevated myc levels are from cells that failed to differentiate efficiently (as in Fig. 2 ). It is relevant that by the criteria of appearance, adherence to the plate, yield of RNA, and level of expression of cytoplasmic -y-actin RNA (Fig. 3) conditions tested. Also, changes in myc RNA levels in 3T3 and MT-myc 3T3 cells have been found to reflect similar changes in myc protein levels (54a), although it remains possible that there is some additional control at the translational level for myc or for MyoD (54) in these cells.
Levels of MyoD expression were measured, and they revealed that under all conditions transgene MyoD was expressed. MyoDl control cells expressed lower levels of MyoD than did MT-myc/MyoDl cells, yet both cell lines differentiated well (unless myc was elevated). The probe used to measure MyoD discriminated between the transgene (shown in Fig. 3 ) and endogenous MyoD. In both cell lines the endogenous MyoD gene was silent (37) and therefore made no contribution to overall MyoD levels. In the MTmyc/MyoDl line, levels of MyoD decreased modestly at later time points in the presence of metal ( Fig. 3; for the MyoD probe, compare lane 3 with 4 and lane 5 with 6). However, this decrease is not likely to be the direct cause for inhibition of differentiation, because even the reduced MyoD levels substantially exceed amounts that are sufficient for differentiation in the control MyoDl cell line (Fig. 3, lanes 7  through 12) .
These data, taken together with the levels of myc ex- (Fig. 3, lanes 1, 3 , and 5 compared with lanes 7, 9, and 11, respectively, of the 2.5-day exposure of the myc probe) shows that the two express significantly different levels. c-myc levels that are permissive for differentiation in MT-myc/MyoDl cells exceed those expressed in rapidly proliferating MyoDl cells (e.g., lane 7) and other myoblast cell lines (data not shown). Nevertheless, when the MT-myc gene is induced with zinc, myc levels rise high enough-perhaps over a threshold-to suppress differentiation even in the presence of abundant amounts of MyoD (Fig. 3, lanes 4 and 6) (37) , and no expression was detected even after long autoradiographic exposures (data not shown). However, a similar experiment using a mouse myogenin probe (Fig. 4) shows that myogenin is expressed when cells differentiate (lanes 3, 5, and 9 through 12) but not when cells are proliferating (lanes 1, 2, 7, and 8) or are inhibited from differentiating (lanes 4 and 6). Myogenin is the only member of the MyoD family that has been detected in all differentiated skeletal muscle cell lines examined to date (5, 37, 39) . Consistent with the hypothesis that myogenin has an important function in the differentiation decision, this experiment shows that when c-myc is induced, myogenin expression fails to be activated.
Can myogenin or MyoD-myogenin coexpression bypass the inhibitory effects of myc? The observation that up-regulation of myogenin and subsequent myogenic differentiation are inhibited by elevated c-myc levels led us to hypothesize that the inhibitory effect of c-myc might be bypassed if both myogenin and MyoD were provided. Furthermore, two facts suggested that both myogenic regulators should be required for such a bypass. First, observations of diverse skeletal muscle myocytes lead to a generalization that they always coexpress myogenin and at least one additional HLH myogenic regulator (5, 37, 39) . Second, BC3H1 myoblasts are efficiently inhibited from differentiating in the presence of myogenin-specific antisense oligonucleotides (10) even though they express Myf-5 (5, 39). Thus, in NIH 3T3 cells, perhaps both myogenin and MyoD are needed for activation of differentiation-specific genes, and only if both are provided can c-myc inhibition be relieved.
Since c-myc had already been shown to inhibit myogenesis in transient cotransfection assays with MyoD ( Fig. 1) , a similar experiment was done to test whether myc would suppress differentiation initiated by myogenin. The rat myogenin cDNA (59) was inserted into the pECE vector, and NIH 3T3 cells were transfected with the mixtures indicated in Fig. 5 . The amount of myc plasmid used was one-half the total molar amount of myogenic plasmid. After 3 days in differentiation medium, cells were fixed and immunostained for MHC, and differentiated cells were counted. The results show that MyoD and myogenin act cooperatively when transfected together, in that they convert significantly more NIH 3T3 cells to myocytes than do the same molar doses of myogenin or MyoD alone (cf., reference 49). Nevertheless, c-myc inhibited differentiation whether MyoD, myogenin, or a mixture of the two was used to initiate myogenesis. Thus, although the activation of myogenin that normally accompanies differentiation of MyoDl cells is suppressed by c-myc, myogenin provided ectopically cannot relieve the overall inhibition of differentiation. The straightforward interpreta- individually. pSVmyc (9.1 ,ug) was sometimes included, as indicated, which was half that molar amount. Otherwise, 6.2 pLg of pECE was included to balance the total SV40 promoter content. The transfection procedure was as described in Materials and Methods, except that 70 ,uM chloroquine was added to the medium during the first 6 h of transfection, after which the cells were rinsed with DMEM, fed fresh medium, and then switched to differentiation medium 24 h later for 3 days. After fixing and staining for MHC, positive cells in 15 fields were counted at a 25x magnification. In this experiment, the maximum was 670 differentiated cells counted. Two repetitions of this experiment yielded similar qualitative results. tion is that in these cells, MyoD and myogenin together may be necessary for differentiation, but they are not sufficient to force differentiation in the presence of c-myc.
Expression of Id is not influenced by ectopic c-myc levels and is down-regulated even in cells inhibited from differentiating. The pattern of expression of Id, a negative regulator of MyoD-initiated muscle gene transcription (2), parallels the pattern of endogenous c-myc expression during myogenesis. Both are expressed at relatively high levels during proliferation compared with those expressed upon differentiation. This raised the possibility of a hierarchical relationship between the two in which elevated c-myc would exert its phenotypic effect by driving expression of Id. Thus, in our studies, myc might inhibit differentiation indirectly by positively regulating expression of Id in zinc-induced MT-mycl MyoDl cells under mitogen-poor conditions, whereas Id levels would be down-regulated in the absence of zinc because of lower levels of c-myc. However, a direct experimental test of this possibility found Id to be down-regulated identically in the presence and absence of suppressing levels of c-myc. Figure 6 shows that even in cells that are inhibited from differentiating by c-myc (lanes 4 and 6), Id levels are no higher than those in cells that have differentiated (lanes 3, 5, and 9 through 12). Thus, while c-myc and Id are normally DISCUSSION c-myc is normally expressed in proliferating myoblasts and is down-regulated upon differentiation into myocytes (22, 51) . We have begun to dissect the regulatory effects of c-myc on myogenesis initiated by MyoD, myogenin, or a combination of the two. In these experiments, expression of c-myc has been uncoupled from environmental and cellular factors which normally influence its regulation. The central result is that preventing the drop in c-myc expression that normally occurs at the onset of differentiation results in inhibition of muscle differentiation.
Comparison of myc-mediated inhibition with effects of other negative regulators. Our experiments suggest a significant role for c-myc in the differentiation decision which differs from the roles of other negative regulators tested in previous studies. Earlier steps in myogenesis are affected by perturbations in ras (32, 35, 43, 44, 53) , proliferin (58), c-fos (35) , and perhaps src (24) , all leading to suppression of muscle differentiation, though there are conflicting results in some systems (27) . Mutant-activated ras and excessfos have been shown to prevent or reduce transcription of the endogenous MyoD gene (32, 35) , and in one study activated ras-dependent inhibition of myogenic differentiation was shown to be accompanied by an up-regulation of c-myc RNA, even in differentiation medium (43) . Proliferin appears to act by reducing the level of MyoD expression or by altering the MyoD transcript, perhaps making it nonfunctional as MyoD mRNA (58) . In contrast to these examples of myogenic inhibition, which act on regulation of MyoD, we have shown that c-myc is able to inhibit differentiation in cell lines at a more distal point in the regulatory pathway-even in the presence of constitutive MyoD. However, while our use of the NIH 3T3 cell line afforded experimental control of MyoD levels in the absence of endogenous MyoD expression, it prevented us from determining whether c-myc, like activated ras and fos, can down-regulate an active endogenous MyoD gene. A further observation in our study is that the c-myc inhibition of cellular differentiation cannot be overcome by expression of myogenin, alone or in conjunction with MyoD. By contrast, in the case of activated ras orfos, constitutive MyoD from a stably transfected cDNA bypassed their suppressing effects (32, 35) .
While the present study shows that c-myc inhibits myogenic differentiation effectively in both transient and stable (48) . a While many cell lines fuse into multinucleated myotubes concurrent with biochemical differentiation, BC3H1 cells do not; however, transfection of a MyoD expression vector into these cells corrects the fusion defect (8) . b While we find that differentiated C2C12 cells express all four myogenic regulators, many cell lines express only myogenin and either MyoD (e.g., MM14 cells) or Myf-5 (e.g., BC3H1 cells) but not both. c Although we have detected myogenin RNA in nominally proliferating MM14 and C2C12 cells (37, 39) , this is presumed to be contributed by spontaneously differentiated cells, which are frequently found in those cultures even in the presence of high levels of growth factors. d We detect herculin in differentiated C2C12 cells (37) and at much lower levels in both proliferating and differentiated BC3H1 cells (36a); low level expression of MRF4 (the herculin homolog in rats) has been reported in differentiated L6 cells (47) and in L8 cells (6) .
Otherwise, while herculin is abundantly expressed in adult mouse skeletal muscle tissue, it is rarely expressed in cultured cell lines. However, myf-6 (the herculin homolog in humans) is expressed in primary human myocytes in culture (6) . (B) A speculative model for a myogenic regulatory network. Arrows represent activation, loops represent autoregulation, bars represent inhibition, and curves represent cooperative activation. E12 is meant to be representative of the several known daughterless homologs which can heterooligomerize with the MyoD family members. transfection formats, the situation for ras and fos is more complicated. Their inhibitory effects can be bypassed by stable transfection with a MyoD expression vector, yet they cannot be bypassed when transiently cotransfected with MyoD and a muscle-specific chloramphenicol acetyltransferase reporter gene into C3H 1OT1/2 cells (35) . In that report (35) 54) , nor is it known whether myogenin is expressed or whether c-myc is up-regulated (as in reference 43). Whatever the explanation for the differences observed in the two assays, the results show that activated ras or excess fos may also act at a step later than MyoD expression, as c-myc clearly does.
Mechanisms of c-myc action. What are the possible mechanisms for c-myc inhibition of muscle differentiation? c-myc is localized in nuclei and contains motifs characteristic of sequence-specific DNA-binding proteins, including the B-HLH motif, essential for oligomerization and function of MyoD family regulators (16, 41) , and a leucine zipper, a motif known to function in dimerization of other transcription factors such as fos and jun (33) . These characteristics suggest two direct mechanisms for myogenic inhibition. In one, myc would bind to promoters or enhancers of downstream muscle-specific genes and act as a repressor. An alternative direct mechanism would have myc inactivate positive-acting muscle-specific transcription factors of the MyoD type by binding to them or to an essential limiting partner. Indeed, the apparent sensitivity of c-myc inhibition to the myc-to-MyoD ratio (shown in this study) is consistent with such a titration by c-myc. However, attempts to achieve dimerization of c-myc with these (or other) potential partners in standard in vitro assays have thus far failed (31) . Moreover, strong evidence supporting sequence-specific DNA binding for myc is also lacking, though myc does have a general affinity for DNA (19, 45) . Nevertheless, the initial negative results of such in vitro studies do not convincingly rule out the mechanisms outlined above.
Less direct mechanisms to explain c-myc effects on differentiation must also be considered. c-myc was first identified as an oncogene, thereby implicating it in the control of cell proliferation. More recent studies assign c-myc a significant role in regulating entry into G1 and S phases of the cell cycle (11) . This is relevant to skeletal myogenesis because it is well established that the permissive point in the cell cycle for the onset of differentiation is the Go-G1 boundary (13) . Thus, since c-myc can drive a subset of quiescent NIH 3T3 cells out of Go and into G1 and S phases, its ability to inhibit differentiation may be secondary to its ability to activate genes involved in progression through the cell cycle. Arguing against this view are two observations. (i) Up to 75% of MT-myc/MyoDl cells differentiated in some of our experiments, and the extent of inhibition by c-myc induction exceeded 80%o, thus involving a far larger fraction of MTmyc cells than can ever be forced into S phase by a myc induction, which is -30% (36b). (ii) Although progression into S phase does not appear to fully explain the observed phenotype, a myc-mediated progression into a position in G1 which is prohibitive for differentiation is possible. While definitive studies will require isolation and use of markers that subdivide progress into and through G1, our data showing a lack of Id expression characteristic of cycling cells (Fig. 6 ) also argue against a mechanism dependent on cycling.
Positive and negative regulatory pathways of myogenesis in cultured cell lines. Figure 7A summarizes the expression patterns of positively and negatively acting myogenic regulatory genes in cell lines in culture and includes the expres-sion pattern of some mature muscle markers. These data provide the biological context for a simple speculative model based upon the observations in this paper together with prior studies (Fig. 7B) . It accommodates the effects of the positive-and negative-acting regulators presently known and integrates data from naturally occurring myogenic cell lines as well as transfection-initiated myoblast lines. The first step identified is determination, the transition from a multipotential stem cell to a myoblast. Here it is accomplished by expression of MyoD, although in other instances Myf-5 might substitute at this step. As indicated, MyoD is sometimes (but not always) able to establish an autoregulatory loop (55) . The initial trigger of MyoD expression is presently unknown, but one plausible candidate is the genetically defined myd locus, which has been shown to activate MyoD when transfected into nonmyogenic cells (46) . The ski oncogene, which can also convert fibroblasts to myoblasts in transfection assays (15) , may also be involved. Negative regulators that act by disrupting MyoD expression include activated ras, excess c-fos, and proliferin, and they appear to be able to function even after the MyoD autoregulatory loop has been established (32, 35, 58) . c-myc and Id have not yet been formally tested for a similar negative effect on MyoD expression in proliferating myoblasts. However, under growth factor-rich conditions that support proliferation of MyoD-positive myoblasts, significant levels of both c-myc and Id have been found in all cases, and we therefore think it is very likely that their expression is compatible with expression of MyoD.
At the next step in the pathway, MyoD-positive myoblasts are signalled to differentiate, which is accomplished in vitro by removing serum growth factors. A rapid response to reduced growth factors is a drop in Id and c-myc expression. One expected result will be the release of any B-HLH proteins that were previously nonfunctional because of sequestration by Id through protein-protein interactions. Indeed, E12 and MyoD both bind efficiently to Id in vitro, and this association inactivates their DNA-binding capacities. These observations led Benezra et al. (2) to propose that a MyoD/E12 hetero-oligomer is necessary for the onset of differentiation, and this activation step is indicated as the early phase of differentiation in Fig. 7B . Within the resolution of our kinetic measurements, myogenin expression begins concurrent with the drop in Id and c-myc; myogenin then appears to be able to positively autoregulate (5, 20) . Experiments presented here and by Benezra et al. (2) indicate that this kinetically early step in differentiation (relative to MHC and MCK expression) is inhibited by c-myc and Id. Additionally, Lassar et al. (35) provide evidence that high levels of mutant ras orfos relative to MyoD also inhibit the myogenin activation step, and the results of Olson et al. (43) suggest that such inhibition by activated ras may actually be mediated by up-regulation of c-myc expression. Since myogenin has been found to be expressed in all differentiating myogenic cell lines examined (5, 37, 39) , this step may be essential for differentiation. Direct support for this comes from studies which show that BC3H1 and L6-A1 myoblasts are efficiently inhibited from differentiating in the presence of myogenin-specific antisense oligonucleotides (10, 25) .
As differentiation proceeds, muscle-specific genes such as those encoding MHC and MCK are transcribed, and in some cases, cell fusion occurs to produce terminally differentiated myotubes. As E12 can dimerize with myogenin (9) as well as with MyoD (2, 41) and can bind to essential cis-acting elements in muscle-specific enhancers, both myogenin-E12 and MyoD-E12 complexes are good candidates for playing a central role in transcriptional activation of terminal differentiation genes. This final step in Fig. 7B is responsive to inhibition by ectopic c-myc expression, as demonstrated in our cotransfections using c-myc, myogenin, and MyoD. Id has not yet been formally tested for its ability to inhibit similarly in the presence of MyoD and myogenin. However, the molecular data showing that Id can inactivate E12 in vitro (2) suggest that ectopic Id expression will also block the final step of differentiation.
The group of positive and negative myogenic regulatory factors presented in Fig. 7 should not allow for differentiation if Id expression is maintained. Therefore, the minimal requirement for premature activation of muscle-specific genes in myoblasts would be the inactivation of both c-myc and Id.
The existence of at least two independent negative regulators of muscle differentiation may be useful to the organism, because such redundancy would ensure that differentiation does not occur before myoblasts have migrated to their proper locations in the developing embryo and have proliferated sufficiently to properly fill their compartments. Because of its positive effects on progression through the cell cycle and its negative effects on differentiation, c-myc appears well suited as a physiological regulator that simultaneously prevents premature differentiation and promotes expansion of precursor cell numbers in lineages where linkage of these activities is important.
